Beyond Stage IV: Rethinking Oligometastatic Lung Cancer

Lung Cancer Considered by Lung Cancer Considered

Sep 1, 202600:47:30Science & Medicine

In this episode, Dr. Narjust Florez is joined by Dr. Yasir Elamin and Dr. Liliana Faroni to explore the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use con...

Related Episodes

Continue listening to more episodes from Lung Cancer Considered.

Before You Go: A Practical Guide to WCLC 2026 in Seoul

Sep 4, 2026 - 00:38:27

Get ready for WCLC 2026 in Seoul with Lung Cancer Considered hosts Dr. Stephen Liu and Dr. Narjust Florez...

LCC in Korean: The Role of Immunotherapy in Lung Cancer

Aug 28, 2026 - 00:46:42

In this Korean-language episode of Lung Cancer Considered, Dr. Chul Kim is joined by Dr. Hye-Ryun Kim and...

The Global Fight Against Lung Cancer: A Conversation with WHO's José Luis Castro

Aug 25, 2026 - 00:29:24

Host Dr. Stephen Liu is joined by José Luis Castro, WHO Director-General Special Envoy for Chronic Respir...

LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

Aug 18, 2026 - 00:47:14

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Mi...

LCC Advances in ALK+ Cancer in Cantonese

Aug 14, 2026 - 00:46:26

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li mod...

Treating Advanced Thymic Cancers

Aug 4, 2026 - 00:59:23

Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and mul...

FDA Approval: Zidesamtinib and ROS1 NSCLC

Jul 28, 2026 - 00:24:01

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib...

Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

Jul 21, 2026 - 00:47:39

How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung...